165 related articles for article (PubMed ID: 8359912)
1. Comparison of gamma interferon, tumor necrosis factor, and direct cell contact in activation of antimycobacterial defense in murine macrophages.
Sypek JP; Jacobson S; Vorys A; Wyler DJ
Infect Immun; 1993 Sep; 61(9):3901-6. PubMed ID: 8359912
[TBL] [Abstract][Full Text] [Related]
2. Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.
Luo Y; Yamada H; Chen X; Ryan AA; Evanoff DP; Triccas JA; O'Donnell MA
Clin Exp Immunol; 2004 Jul; 137(1):24-34. PubMed ID: 15196240
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide production by peritoneal macrophages of Mycobacterium bovis BCG-infected or non-infected mice: regulatory role of T lymphocytes and cytokines.
Saito S; Nakano M
J Leukoc Biol; 1996 Jun; 59(6):908-15. PubMed ID: 8691077
[TBL] [Abstract][Full Text] [Related]
4. Soluble TNF and membrane TNF expressed on CD4+ T lymphocytes differ in their ability to activate macrophage antileishmanial defense.
Birkland TP; Sypek JP; Wyler DJ
J Leukoc Biol; 1992 Mar; 51(3):296-9. PubMed ID: 1347312
[TBL] [Abstract][Full Text] [Related]
5. Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor.
Flesch IE; Kaufmann SH
Infect Immun; 1990 Aug; 58(8):2675-7. PubMed ID: 2115027
[TBL] [Abstract][Full Text] [Related]
6. A tumor necrosis factor mimetic peptide activates a murine macrophage cell line to inhibit mycobacterial growth in a nitric oxide-dependent fashion.
Britton WJ; Meadows N; Rathjen DA; Roach DR; Briscoe H
Infect Immun; 1998 May; 66(5):2122-7. PubMed ID: 9573098
[TBL] [Abstract][Full Text] [Related]
7. Antimycobacterial functions in bone-marrow-derived macrophages.
Kaufmann SH; Flesch IE
Res Microbiol; 1990 Feb; 141(2):244-8. PubMed ID: 2111926
[No Abstract] [Full Text] [Related]
8. Cytokine-mediated activation of macrophages from Mycobacterium bovis BCG-resistant and -susceptible mice: differential effects of corticosterone on antimycobacterial activity and expression of the Bcg gene (Candidate Nramp).
Brown DH; LaFuse W; Zwilling BS
Infect Immun; 1995 Aug; 63(8):2983-8. PubMed ID: 7622220
[TBL] [Abstract][Full Text] [Related]
9. Cell contact-mediated macrophage activation for antileishmanial defense. I. Lymphocyte effector mechanism that is contact dependent and noncytotoxic.
Panosian CB; Sypek JP; Wyler DJ
J Immunol; 1984 Dec; 133(6):3358-65. PubMed ID: 6208278
[TBL] [Abstract][Full Text] [Related]
10. Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon.
Hori K; Ehrke MJ; Mace K; Mihich E
Cancer Res; 1987 Nov; 47(22):5868-74. PubMed ID: 3117358
[TBL] [Abstract][Full Text] [Related]
11. TNF-alpha controls intracellular mycobacterial growth by both inducible nitric oxide synthase-dependent and inducible nitric oxide synthase-independent pathways.
Bekker LG; Freeman S; Murray PJ; Ryffel B; Kaplan G
J Immunol; 2001 Jun; 166(11):6728-34. PubMed ID: 11359829
[TBL] [Abstract][Full Text] [Related]
12. Growth inhibition of Mycobacterium bovis by IFN-gamma stimulated macrophages: regulation by endogenous tumor necrosis factor-alpha and by IL-10.
Flesch IE; Hess JH; Oswald IP; Kaufmann SH
Int Immunol; 1994 May; 6(5):693-700. PubMed ID: 8080840
[TBL] [Abstract][Full Text] [Related]
13. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.
Jiang H; Stewart CA; Fast DJ; Leu RW
J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576
[TBL] [Abstract][Full Text] [Related]
14. TLR2 but not TLR4 signalling is critically involved in the inhibition of IFN-gamma-induced killing of mycobacteria by murine macrophages.
Arko-Mensah J; Julián E; Singh M; Fernández C
Scand J Immunol; 2007 Feb; 65(2):148-57. PubMed ID: 17257219
[TBL] [Abstract][Full Text] [Related]
15. A novel tumor necrosis factor (TNF) mimetic peptide prevents recrudescence of Mycobacterium bovis bacillus Calmette-Guerin (BCG) infection in CD4+ T cell-depleted mice.
Briscoe H; Roach DR; Meadows N; Rathjen D; Britton WJ
J Leukoc Biol; 2000 Oct; 68(4):538-44. PubMed ID: 11037976
[TBL] [Abstract][Full Text] [Related]
16. Neutralization of gamma interferon and tumor necrosis factor alpha blocks in vivo synthesis of nitrogen oxides from L-arginine and protection against Francisella tularensis infection in Mycobacterium bovis BCG-treated mice.
Green SJ; Nacy CA; Schreiber RD; Granger DL; Crawford RM; Meltzer MS; Fortier AH
Infect Immun; 1993 Feb; 61(2):689-98. PubMed ID: 8423095
[TBL] [Abstract][Full Text] [Related]
17. Cellular responses and Mycobacterium bovis BCG growth inhibition by bovine lymphocytes.
Carpenter E; Fray L; Gormley E
Immunol Cell Biol; 1997 Dec; 75(6):554-60. PubMed ID: 9492191
[TBL] [Abstract][Full Text] [Related]
18. Ability of T cell subsets and their soluble mediators to modulate the replication of Mycobacterium bovis in bovine macrophages.
Denis M; Wedlock DN; Buddle BM
Cell Immunol; 2004; 232(1-2):1-8. PubMed ID: 15922710
[TBL] [Abstract][Full Text] [Related]
19. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma.
Stuehr DJ; Marletta MA
J Immunol; 1987 Jul; 139(2):518-25. PubMed ID: 3110273
[TBL] [Abstract][Full Text] [Related]
20. Role of cytokines and nitric oxide in the induction of tuberculostatic macrophage functions.
Petricevich VL; Alves RC
Mediators Inflamm; 2000; 9(6):261-9. PubMed ID: 11213909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
